DURECT (DRRX) News Today $0.78 -0.02 (-1.99%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period StockNews.com Begins Coverage on DURECT (NASDAQ:DRRX)April 4 at 2:09 AM | americanbankingnews.comOppenheimer Sticks to Its Buy Rating for Durect (DRRX)March 30, 2025 | markets.businessinsider.comHere's Why We're A Bit Worried About DURECT's (NASDAQ:DRRX) Cash Burn SituationMarch 28, 2025 | finance.yahoo.comDURECT Corporation (NASDAQ:DRRX) Q4 2024 Earnings Call TranscriptMarch 28, 2025 | msn.comDURECT (NASDAQ:DRRX) Given "Neutral" Rating at HC WainwrightMarch 28, 2025 | americanbankingnews.comDURECT outlines $20M Phase 3 trial for larsucosterol in alcohol-associated hepatitisMarch 27, 2025 | msn.comDURECT (NASDAQ:DRRX) Earns Sell Rating from Analysts at StockNews.comMarch 27, 2025 | americanbankingnews.comDURECT Corporation (DRRX) Q4 2024 Earnings Call TranscriptMarch 26, 2025 | seekingalpha.comDURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 26, 2025 | prnewswire.comDURECT Q4 2024 Earnings PreviewMarch 25, 2025 | msn.comDURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business UpdateMarch 19, 2025 | prnewswire.comDurect Corporation Announces Board Member’s RetirementFebruary 21, 2025 | tipranks.comDURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 4, 2025 | prnewswire.comH.C. Wainwright views Durect as significant ‘going concern’ riskJanuary 30, 2025 | markets.businessinsider.comDURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM EvidenceJanuary 28, 2025 | prnewswire.comOppenheimer Remains a Buy on Durect (DRRX)November 27, 2024 | markets.businessinsider.comDurect announces sale of Alzet line of osmotic pumps to LIC for $17.5MNovember 26, 2024 | markets.businessinsider.comDurect (DRRX) Gets a Buy from Northland SecuritiesNovember 26, 2024 | markets.businessinsider.comDURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 MillionNovember 25, 2024 | prnewswire.comDURECT Corporation (NASDAQ:DRRX) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | msn.comDURECT Corporation (DRRX) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comDURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 13, 2024 | prnewswire.comAn Overview of Durect's EarningsNovember 13, 2024 | benzinga.comDURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business UpdateNovember 6, 2024 | prnewswire.comDURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024October 17, 2024 | prnewswire.comDurect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Advances Amid ...October 10, 2024 | finance.yahoo.comDURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated HepatitisSeptember 25, 2024 | prnewswire.comDURECT Corporation to Present at the H.C. Wainwright Global Investment ConferenceSeptember 4, 2024 | prnewswire.comDRRX Apr 2025 2.000 putAugust 29, 2024 | ca.finance.yahoo.comDRRX Apr 2025 2.000 callAugust 29, 2024 | ca.finance.yahoo.comDURECT Corporation (DC8A.F)August 22, 2024 | uk.finance.yahoo.comDURECT Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 17, 2024 | finance.yahoo.comDURECT Corporation (DRRX) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | seekingalpha.comDURECT Corp. Q2 Loss Decreases, Beats EstimatesAugust 13, 2024 | markets.businessinsider.comDURECT Corporation Reports Second Quarter 2024 Financial Results and Business UpdateAugust 13, 2024 | prnewswire.comDURECT Corporation (DRRX) Latest Stock News & Headlines - Yahoo FinanceAugust 12, 2024 | ca.finance.yahoo.comDURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business UpdateAugust 7, 2024 | prnewswire.comDRRX Aug 2024 1.000 putAugust 4, 2024 | ca.finance.yahoo.comDURECT (NASDAQ:DRRX) Stock Price Crosses Above 200-Day Moving Average of $1.13DURECT (NASDAQ:DRRX) Stock Price Crosses Above 200-Day Moving Average of $1.13July 30, 2024 | marketbeat.comDurect Corp (DC8A.SG)July 20, 2024 | finance.yahoo.comDURECT Co. (NASDAQ:DRRX) Receives Consensus Recommendation of "Moderate Buy" from AnalystsDURECT Co. (NASDAQ:DRRX - Get Free Report) has earned an average recommendation of "Moderate Buy" from the five research firms that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and three have issued a buy reJune 15, 2024 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Durect (DRRX)May 22, 2024 | markets.businessinsider.comDURECT gets FDA breakthrough therapy status for larsucosterolMay 21, 2024 | msn.comDURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated HepatitisMay 21, 2024 | prnewswire.comDURECT Corporation (NASDAQ:DRRX) Q1 2024 Earnings Call TranscriptMay 14, 2024 | msn.comDurect Corp (DRRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Challenges ...May 14, 2024 | finance.yahoo.comDURECT Corporation Reports First Quarter 2024 Financial Results and Business UpdateMay 13, 2024 | prnewswire.comDURECT Q1 2024 Earnings PreviewMay 12, 2024 | msn.comDURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business UpdateMay 7, 2024 | prnewswire.comDURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated HepatitisApril 30, 2024 | prnewswire.com Remove Ads Get DURECT News Delivered to You Automatically Sign up to receive the latest news and ratings for DRRX and its competitors with MarketBeat's FREE daily newsletter. Email Address DRRX Media Mentions By Week DRRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRRX News Sentiment▼-0.150.61▲Average Medical News Sentiment DRRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRRX Articles This Week▼41▲DRRX Articles Average Week Remove Ads Get DURECT News Delivered to You Automatically Sign up to receive the latest news and ratings for DRRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies XBIT News Today IMUX News Today SLS News Today EDIT News Today TELO News Today CHRS News Today VXRT News Today GNLX News Today OPTN News Today ANIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRRX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DURECT Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share DURECT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.